|
PNPT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.759100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.079000E-03 |
| Normal-vs-Stage2 |
3.876200E-01 |
| Normal-vs-Stage3 |
2.829800E-01 |
| Normal-vs-Stage4 |
2.674800E-01 |
| Stage1-vs-Stage2 |
6.022400E-01 |
| Stage1-vs-Stage3 |
5.511000E-01 |
| Stage1-vs-Stage4 |
9.713000E-01 |
| Stage2-vs-Stage3 |
9.970800E-01 |
| Stage2-vs-Stage4 |
7.854800E-01 |
| Stage3-vs-Stage4 |
7.671000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.164600E-03 |
| Normal-vs-AfricanAmerican |
7.420100E-02 |
| Normal-vs-Asian |
8.993200E-01 |
| Caucasian-vs-AfricanAmerican |
6.800000E-01 |
| Caucasian-vs-Asian |
5.189600E-01 |
| AfricanAmerican-vs-Asian |
6.163400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.001060E-04 |
| Normal-vs-Female |
9.332800E-01 |
| Male-vs-Female |
1.597500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.347800E-02 |
| Normal-vs-Extreme_Weight |
2.09569999999326E-05 |
| Normal-vs-Obese |
1.565600E-01 |
| Normal-vs-Extreme_Obese |
5.201200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.865400E-01 |
| Normal_Weight-vs-Obese |
6.045200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.057600E-01 |
| Extreme_Weight-vs-Obese |
9.666300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.626800E-01 |
| Obese-vs-Extreme_Obese |
9.602000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.483200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.042400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.315900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.344080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.516300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.728400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.248500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.308200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.885850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.152200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.244700E-03 |
| Normal-VS-Type2 PRCC |
1.018020E-02 |
| Normal-VS-KIRP CIMP |
4.430400E-01 |
| Normal-VS-Unclassified PRCC |
2.433800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.200400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.729440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.974400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.377600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.587400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.546630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.92040000002169E-06 |
| Normal-vs-N1 |
9.764400E-01 |
| Normal-vs-N2 |
4.313400E-01 |
| N0-vs-N1 |
2.964500E-02 |
| N0-vs-N2 |
8.370000E-01 |
| N1-vs-N2 |
4.244400E-01 |
|
|
